Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Epigenetics and Nuclear Signaling >> Transcription >> Polymerase associated factors >> Pol II Transcription >> TFIID
Anti-TAF9 antibody
See all TAF9 products (3) ...
Rabbit polyclonal to TAF9
ab30963 recognises transcription initiation factor TFIID subunit 9 (TAF9)
WB, ELISA, IHC-Pmore details
Reacts with
Human
Predicted to work with
Mouse, Cow, Dog
Synthetic peptide derived from residues 28 - 77 of human TAF9.
.
WB: fetal small intestine lysate IHC: human skin
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
Preservative: None
Constituents: 2% Sucrose, PBS
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Our Abpromise guarantee covers the use of ab30963 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 0.125 µg/mlDetects a band of approximately 20 kDa (predicted molecular weight: 29 kDa).
ELISA: 1/312500
IHC-P: Use a concentration of 4 - 8 µg/ml.
TAF9 functions as a component of the DNA-binding general transcription factor complex TFIID and the regulatory transcription complex SAGA. Binding of TFIID to a promoter (with or without TATA element) is the initial step in pre-initiation complex (PIC) formation. TFIID plays a key role in the regulation of gene expression by RNA polymerase II through different activities such as transcription activator interaction, core promoter recognition and selectivity, TFIIA and TFIIB interaction, chromatin modification (histone acetylation by TAF1), facilitation of DNA opening and initiation of transcription. SAGA influences RNA polymerase II transcriptional activity through different activities such as TBP interaction (SPT3 and SPT8) and promoter selectivity, interaction with transcription activators (GCN5, ADA2, ADA3, and TRA1), and chromatin modification through histone acetylation (GCN5).
Nuclear
Western blot - TAF9 antibody (ab30963)

Anti-TAF9 antibody (ab30963) at 0.125 µg/ml + Fetal small intestine lysate
Secondary
HRP conjugated anti-rabbit IgG
Predicted band size : 29 kDa
Observed band size : 15,20 kDa (why is the actual band size different from the predicted?)
ab30963 has not yet been referenced specifically in any publications.
Publishing research using ab30963? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Anti-TAF9 antibody (ab30963) at 0.125 µg/ml + Fetal small intestine lysate
Secondary
HRP conjugated anti-rabbit IgG
Predicted band size : 29 kDa
Observed band size : 15,20 kDa (why is the actual band size different from the predicted?)
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
